CAmpto-CISplatine Plus Radiotherapy in Advanced Cervix Cancer : Search of Tolerated Maximum Dose of Campto
PHASE1CompletedINTERVENTIONAL
Enrollment
15
Participants
Timeline
Start Date
November 30, 2002
Study Completion Date
November 30, 2005
Conditions
Cervix Cancer
Interventions
DRUG
campto (irinotecan)
DRUG
cisplatin (cisplatyl)
Trial Locations (2)
31052
Centre Claudius Régaud, Toulouse
34298
CRLC Val d'Aurelle, Montpellier
All Listed Sponsors
lead
ARCAGY/ GINECO GROUP
OTHER
NCT00251888 - CAmpto-CISplatine Plus Radiotherapy in Advanced Cervix Cancer : Search of Tolerated Maximum Dose of Campto | Biotech Hunter | Biotech Hunter